Related Experiment Video

Updated: Jun 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Management of severe community-acquired pneumonia of children in developing and developed countries

Nicola Principi1, Susanna Esposito

  • 1Department of Maternal and Paediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milano, Italy. nicola.principi@unimi.it

Thorax
|October 23, 2010
PubMed

Insights

Severe childhood community-acquired pneumonia (CAP) is rising globally, increasing risks of hospitalization and death. Prompt diagnosis and effective treatment are crucial for reducing pediatric CAP morbidity and mortality.

Area of Science:

  • Pediatric infectious diseases
  • Pulmonology
  • Critical care medicine

Background:

  • Childhood community-acquired pneumonia (CAP) is a significant global health concern.
  • Increasing incidence of severe CAP cases worldwide necessitates focused attention.
  • Severe CAP poses the highest risk for hospitalization, prolonged illness, and mortality.

Purpose of the Study:

  • To review current data on diagnosing and treating severe/complicated pediatric CAP.
  • To identify knowledge gaps and areas needing further research.
  • To inform evidence-based recommendations for managing severe pediatric CAP.

Main Methods:

  • Comprehensive literature review of studies on pediatric CAP diagnosis and treatment.
  • Evaluation of data from developed and developing countries.
  • Synthesis of existing evidence on severe and complicated CAP cases.

Main Results:

  • Severe CAP is associated with increased risks of severe outcomes, including death.
  • Current evidence highlights the need for improved diagnostic and treatment strategies.
  • Significant research gaps exist regarding etiology, optimal antibiotic therapy, surgical indications, and physiotherapy.

Conclusions:

  • Effective management of severe pediatric CAP requires prompt identification and treatment.
  • Further research is essential to refine treatment protocols and reduce CAP-related mortality.
  • Evidence-based guidelines for severe pediatric CAP are needed, informed by ongoing research.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...